tbuckley/cabot-search huggingface dataset:
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Early Triple-Negative Breast Cancer—Reply
Authors: Ke-Da Yu, Zhi-Ming Shao
Journal: JAMA Oncology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus
Authors: Ana C. F. Ferreira, Aydan C. H. Szeto, Morgan W. D. Heycock, Paula A. Clark, Jennifer A. Walker, Alastair Crisp, Jillian L. Barlow, Sophie Kitching, Alfred Lim, Mayuri Gogoi, Richard Berks, Maria Daly, Helen E. Jolin, Andrew N. J. McKenzie
Journal: Nature Immunology (2021)
Levamisole-Induced Vasculopathy
Authors: Cristina López-Sánchez, Eduardo Rozas-Muñoz, Juan Francisco Mir-Bonafé
Journal: JAMA Dermatology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
Abstract 14890: E-cigarette Use Leads to Impaired Coronary Endothelial Function in Young Adults
Authors: Mohamad Rashid, Katherine Davoren, Norma B Moy, Fida Nafeh, Robert Elashoff, Chulkyu Kim, Elizabeth Kim, Susan Cheng, Florian Rader
Journal: Circulation (2019)

Background: Electronic (e-) cigarettes are marketed as a safer alternative to tobacco cigarettes. While providing a lower level of nicotine, the e-cigarette delivery method involves creating an aer...
Abstract 15538: Optimizing a Photophletysmography Algorhythm for Atrial Fibrillation Detection Using Crowdsourcing Research Data
Authors: Daniel Mol, Yosef Safi Harb, Trudie C Lobban, Robert K Riezebos, Joris R de Groot, Jonas S de Jong
Journal: Circulation (2018)

Introduction: Photoplethysmography (PPG) records the reflection of light in blood perfused tissues, and can be used for heart rhythm analysis. Advances in smartphone technology allow real time PPG ...
CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma
Authors: Chester Lai, George Coltart, Andrew Shapanis, Conor Healy, Ahmad Alabdulkareem, Sara Selvendran, Jeffrey Theaker, Matthew Sommerlad, Matthew Rose-Zerilli, Aymen Al-Shamkhani, Eugene Healy
Journal: Journal for ImmunoTherapy of Cancer (2021)

Background Tumor infiltrating lymphocytes play a key role in antitumor responses; however, while several memory T-cell subtypes have been reported in inflammatory and neoplastic conditions, the proportional representation of the different subsets of memory T cells and their functional significance in cancer is unclear. Keratinocyte skin cancer is one of the most common cancers globally, with cutaneous squamous cell cancer (cSCC) among the most frequent malignancies capable of metastasis. Methods Memory T-cell subsets were delineated in human cSCCs and, for comparison, in non-lesional skin and blood using flow cytometry. Immunohistochemistry was conducted to quantify CD103+ cells in primary human cSCCs which had metastasized (P-M) and primary cSCCs which had not metastasized (P-NM). TIMER2.0 (timer.cistrome.org) was used to analyze TCGA cancer survival data based on ITGAE expression. Immunofluorescence microscopy was performed to determine frequencies of CD8+CD103+ cells in P-M and P-NM cSCCs. Results Despite intertumoral heterogeneity, most cSCC T cells were CCR7−/CD45RA− effector/resident memory (TRM) lymphocytes, with naive, CD45RA+/CCR7− effector memory re-expressing CD45RA, CCR7+/L-selectin+ central memory and CCR7+/L-selectin− migratory memory lymphocytes accounting for smaller T-cell subsets. The cSCC CD8+ T-cell population contained a higher proportion of CD69+/CD103+ TRMs than that in non-lesional skin and blood. These cSCC CD69+/CD103+ TRMs exhibited increased IL-10 production, and higher CD39, CTLA-4 and PD-1 expression compared with CD103− TRMs in the tumor. CD103+ cells were more frequent in P-M than P-NM cSCCs. Analysis of TCGA data demonstrated that high expression of ITGAE (encoding CD103) was associated with reduced survival in primary cutaneous melanoma, breast carcinoma, renal cell carcinoma, kidney chromophobe cancer, adrenocortical carcinoma and lower grade glioma. Immunofluorescence microscopy showed that the majority of CD103 was present on CD8+ T cells and that CD8+CD103+ cells were significantly more frequent in P-M than P-NM cSCCs. Conclusion These results highlight CD8+CD103+ TRMs as an important functional T-cell subset associated with poorer clinical outcome in this cancer.
Lymphatic Path of the Inguinal Lymph Node Metastases in Anorectal Cancer
Authors: Georgios Gemenetzis, Vassiliki D Lyra, Sofia N Chatziioannou, Vassilios Smyrniotis, Pantelis Vassiliu
Journal: Clinical Nuclear Medicine (2015)

Sentinel lymph node biopsy has been established as a feasible and effective method for defining the inguinal node status in patients with anal adenocarcinoma exceeding the dentate line. We present the axial lymphoscintigraphic image that depicts thoroughly the injection site around the anus, the lymphatic path, and the inguinal sentinel lymph nodes, bilaterally. The distinct springbok pattern was named after the unique horn shape of the African gazelle. This image puts on the map the anoinguinal lymphatic path and highlights the need for complete inguinal lymph node and related lymphatic path dissection in metastatic anal cancer.
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
Authors: Jingjing Cai, Haomiao Li, Changjiang Zhang, Ze Chen, Hui Liu, Fang Lei, Juan-Juan Qin, Ye-Mao Liu, Feng Zhou, Xiaohui Song, Jianghua Zhou, Yan-Ci Zhao, Bin Wu, Meiling He, Huilin Yang, Lihua Zhu, Peng Zhang, Yan-Xiao Ji, Guang-Nian Zhao, Zhigang Lu, Liming Liu, Weiming Mao, Xiaofeng Liao, Haofeng Lu, Daihong Wang, Xigang Xia, Xiaodong Huang, Xiang Wei, Jiahong Xia, Bing-Hong Zhang, Yufeng Yuan, Zhi-Gang She, Qingbo Xu, Xinliang Ma, Yibin Wang, Juan Yang, Xin Zhang, Xiao-Jing Zhang, Hongliang Li
Journal: Cell Metabolism (2021)
バングラデッシュ国,アライハザールにおける,飲料水ヒ素曝露と児童知的機能
Authors: Wasserman G A, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Van Geen A, Slavkovich, Lolacono N J, Hussain I
Journal: Environmental Health Perspectives (2004)
Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hocevar<i>et al</i>
Authors: Philipp Gauckler, Erica L Bettac, Andreas Kronbichler
Journal: Annals of the Rheumatic Diseases (2021)

In our previous report on antineutrophil cytoplasm antibodies (ANCA)-associated vasculitides (AAV) during the current COVID-19 pandemic, we described our observation of both an incidence-shift with a post-lockdown clustering and an increased incidence rate of AAV diagnoses between February and August 2020 compared with previous years.1

In correspondence to our article, Hocevar et al report how COVID-19 pandemic affected management of patients with vasculitides at their centre. The in-depth analysis examined symptom duration (ie, time eclipsed to final diagnosis), disease activity/severity and seasonal changes of patients presenting with giant cell arteritis, and IgA vasculitis and AAV during 2020 and in the previous decade. No significant differences were found in incidence rates or indications for deferrals; that is, symptoms were experienced for a longer length of time before a diagnosis was made or a more severe presentation occurred.2

As the COVID-19 pandemic remains ongoing, six patients with AAV treated at …
Breathing for Two
Authors: Meghan Rudder, Melissa Russo, Corey E. Ventetuolo
Journal: New England Journal of Medicine (2021)

A 29-year-old pregnant woman (gravida 5, para 3) with undifferentiated connective tissue disease presented at 26 weeks 3 days of gestation with cough and shortness of breath. Two weeks earlier, she had noted gradually increasing exertional dyspnea, 5 days of nonproductive cough, nasal congestion, subjective fevers, and fatigue.
The identification of novel immunogenic antigens as potential Shigella vaccine components
Authors: Ruklanthi de Alwis, Li Liang, Omid Taghavian, Emma Werner, Hao Chung The, Trang Nguyen Hoang Thu, Vu Thuy Duong, D. Huw Davies, Philip L. Felgner, Stephen Baker
Journal: Genome Medicine (2021)

Abstract Background Shigella is a major diarrheal pathogen for which there is presently no vaccine. Whole genome sequencing provides the ability to predict and derive novel antigens for use as vaccines. Here, we aimed to identify novel immunogenic Shigella antigens that could serve as Shigella vaccine candidates, either alone, or when conjugated to Shigella O-antigen. Methods Using a reverse vaccinology approach, where genomic analysis informed the Shigella immunome via an antigen microarray, we aimed to identify novel immunogenic Shigella antigens. A core genome analysis of Shigella species, pathogenic and non-pathogenic Escherichia coli , led to the selection of 234 predicted immunogenic Shigella antigens. These antigens were expressed and probed with acute and convalescent serum from microbiologically confirmed Shigella infections. Results Several Shigella antigens displayed IgG and IgA seroconversion, with no difference in sero-reactivity across by sex or age. IgG sero-reactivity to key Shigella antigens was observed at birth, indicating transplacental antibody transfer. Six antigens (FepA, EmrK, FhuA, MdtA, NlpB, and CjrA) were identified in in vivo testing as capable of producing binding IgG and complement-mediated bactericidal antibody. Conclusions These findings provide six novel immunogenic Shigella proteins that could serve as candidate vaccine antigens, species-specific carrier proteins, or targeted adjuvants.
Abstract 17363: Cardiac Output and Valve Orientation Affect Blood Flow Patterns Local to Bioprosthetic Pulmonary Valves in Tetralogy of Fallot
Authors: Nicole Schiavone, Christopher Elkins, Doff B McElhinney, John K Eaton, Alison L Marsden
Journal: Circulation (2020)

Introduction: Tetralogy of Fallot (ToF) typically requires surgical repair of the right ventricular outflow tract (RVOT) and subsequent placement of an artificial pulmonary valve. Bioprosthetic valve longevity is highly variable and there is currently little understanding of what hemodynamic factors may lead to early valve dysfunction. Hypothesis: We hypothesize that cardiac output and valve orientation impact the performance of bioprosthetic valves by affecting blood flow patterns in the RVOT. Methods: We analyzed hemodynamics in a 3D printed ToF anatomy model in a physiological flow loop. A 25mm surgical valve was implanted in the model at two orientations: native and rotated 180 degrees. Full 3D, three-component, phase-averaged velocity fields were obtained over the cardiac cycle using 4D flow MRI at cardiac outputs of 2, 3.5, and 5 L/min. We acquired images of valve leaflet motion at 1500Hz. The 4D flow MRI and high-speed camera experiments were run identically, allowing us to examine the relationship between flow fields and leaflet motion. Results: The full velocity fields from the MRI scans revealed key differences among cases in flow features including location of reverse flow regions, systolic jet shape, and asymmetry local to the valve. At 2 L/min, the forward flow through the jet was more asymmetric compared to the other cases and a strong vortex formed, indicating a region of recirculation. With the rotated valve orientation, the 2 L/min case also produced a unique pattern as flow was washed from the RVOT inner curve back toward the center of the valve (Fig 1). Leaflet behavior during systole varied with cardiac output as well, as higher frequency flutter was observed at 5 L/min and the effective valve orifice area was decreased by 8.5% at 2 L/min compared to 5 L/min. Conclusions: We observed key differences in flow patterns and leaflet motion due to cardiac output and valve orientation that could impact leaflet loading and fatigue and long-term valve function.
Genetic complexity impacts the clinical outcome of follicular lymphoma patients
Authors: María García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, Cristina Jiménez, M. Eugenia Sarasquete, M. Carmen Chillón, Alejandro Medina, Ana Balanzategui, Rebeca Maldonado, Alicia Antón, Marta Rodríguez, Oscar Blanco, Luis G. Díaz, Pilar Tamayo, Pedro Blanco, Carmen Esteban, Verónica González-Calle, Noemí Puig, Norma Gutiérrez, Alejandro Martín, Ramón García-Sanz, Marcos González, M. Dolores Caballero, Miguel Alcoceba
Journal: Blood Cancer Journal (2021)
Postoperative Atrial Fibrillation After Noncardiac Surgery and Stroke—Reply
Authors: Konstantinos C. Siontis, Bernard J. Gersh, Alanna M. Chamberlain
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 13006: Digital Diabetes Prevention Program Reduces Medical Costs in the First 2 Years of Implementation in a Workplace Setting
Authors: Charles E Birse, Olga A Iakoubova, Andre R Arellano, Maren S Fragala, Lance A Bare, Cynthia M Castro Sweet, Robert J Lagier
Journal: Circulation (2020)

Introduction: The Diabetes Prevention Program (DPP) was shown to reduce body weight and lower incidence of diabetes in a cost-effective manner. Digital versions of the DPP (dDPP) have recently been implemented and shown to reduce body weight and other risk factors for chronic disease. We asked whether implementation of a dDPP in a workplace setting would reduce medical costs. Methods: Employees and spouses of a nation-wide medical diagnostic provider were eligible to participate in dDPP (Omada Health) if they had prediabetes (fasting glucose 100 to 125 mg/dL or HbA 1C 5.7% to 6.4%) and BMI ≥25 kg/m 2 at baseline (September to December 2017), and were continuously enrolled in a health plan from September 2016 to December 2019. Of those eligible (n=3,098), 432 participated and completed ≥1 lesson (dDPP group). A control group (n=856) was matched to the dDPP group by baseline age, sex, race, geography, comorbidities, health plan type, and medical and prescription costs. Generalized estimating equations adjusted for age, race and BMI were used to obtain all estimates. Allowed costs from administrative claims data were evaluated per member per month (PMPM); dDPP costs were not included. Results: In the control group, costs were higher in the post-dDPP period (2017-2019) compared to the pre-dDPP period (2016-2017) for inpatient ($124 vs $64, P= 0.01), prescription ($183 vs $155, P =0.02), and total ($696 vs $558, P &lt;0.001; Figure). In the dDPP group, no changes were observed. Changes in total costs (post-dDPP minus pre-dDPP) were lower in the dDPP group than the control group, with a saving of $141 PMPM ( P =0.02; Figure). Conclusion: In the first two years of dDPP implementation, medical costs were unchanged in dDPP participants but higher in matched controls.
What Is Idiopathic Pulmonary Fibrosis? IPF Part 1
Authors: Sabina A. Guler, Kathleen O. Lindell, Jeff Swigris, Christopher J. Ryerson
Journal: American Journal of Respiratory and Critical Care Medicine (2021)

"What Is Idiopathic Pulmonary Fibrosis? IPF Part 1." American Journal of Respiratory and Critical Care Medicine, 203(2), pp. P5–P6
Antiviral Drug Approved for Postexposure Flu Prevention
Authors: Rebecca Voelker
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Central and peripheral GLP-1 systems independently suppress eating
Authors: Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, Alan de Araujo, Molly McDougle, Macarena Vergara, Majd H. Afaghani, Shin Jae Lee, Karen Scott, Calyn Maske, Wolfgang Langhans, Eric Krause, Annette de Kloet, Fiona M. Gribble, Frank Reimann, Linda Rinaman, Guillaume de Lartigue, Stefan Trapp
Journal: Nature Metabolism (2021)
Fast Strain-Encoded Cardiac Magnetic Resonance for Diagnostic Classification and Risk Stratification of Heart Failure Patients
Authors: Grigorios Korosoglou, Sorin Giusca, Moritz Montenbruck, Amit R. Patel, Tomas Lapinskas, Collin Götze, Victoria Zieschang, Sarah Al-Tabatabaee, Burkert Pieske, Andre Florian, Jennifer Erley, Hugo A. Katus, Sebastian Kelle, Henning Steen
Journal: JACC. Cardiovascular imaging (2021)
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
Authors: Kate Absolom, Lorraine Warrington, Eleanor Hudson, Jenny Hewison, Carolyn Morris, Patricia Holch, Robert Carter, Andrea Gibson, Marie Holmes, Beverly Clayton, Zoe Rogers, Lucy McParland, Mark Conner, Liz Glidewell, Barbara Woroncow, Bryony Dawkins, Sarah Dickinson, Claire Hulme, Julia Brown, Galina Velikova
Journal: Journal of Clinical Oncology (2021)

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during cancer treatment. It provides automated severity-dependent patient advice guiding self-management or medical contact and displays the reports in electronic patient records. This trial evaluated the impact of eRAPID on symptom control, healthcare use, patient self-efficacy, and quality of life (QOL) in a patient population treated predominantly with curative intent.Patients with colorectal, breast, or gynecological cancers commencing chemotherapy were randomly assigned to usual care (UC) or the addition of eRAPID (weekly online symptom reporting for 18 weeks). Primary outcome was symptom control (Functional Assessment of Cancer Therapy-General, Physical Well-Being subscale [FACT-PWB]) assessed at 6, 12, and 18 weeks. Secondary outcomes were processes of care (admissions or chemotherapy delivery), patient self-efficacy, and global quality of life (Functional Assessment of Cancer Therapy-General, EQ5D-VAS, and EORTC QLQ-C30 summary score). Multivariable mixed-effects repeated-measures models were used for analyses. Trial registration: ISRCTN88520246.Participants were 508 consenting patients (73.6% of 690 eligible) and 55 health professionals. eRAPID compared to UC showed improved physical well-being at 6 (P = .028) and 12 (P = .039) weeks and no difference at 18 weeks (primary end point) (P = .69). Fewer eRAPID patients (47%) had clinically meaningful physical well-being deterioration than UC (56%) at 12 weeks. Subgroup analysis found benefit in the nonmetastatic group at 6 weeks (P = .0426), but not in metastatic disease. There were no differences for admissions or chemotherapy delivery. At 18 weeks, patients using eRAPID reported better self-efficacy (P = .007) and better health on EQ5D-VAS (P = .009). Average patient compliance with weekly symptom reporting was 64.7%. Patient adherence was associated with clinician's data use and improved FACT-PWB at 12 weeks.Real-time monitoring with electronic patient-reported outcomes improved physical well-being (6 and 12 weeks) and self-efficacy (18 weeks) in a patient population predominantly treated with curative intent, without increasing hospital workload.
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey
Authors: Manuela Funke-Chambour, Carlo Albera, Elisabeth Bendstrup, Ulrich Costabel, Jan C. Grutters, Sergio Harari, Kerri A. Johannson, Michael Kreuter, Irina Strambu, Carlo Vancheri, Francesco Varone, Patrizio Vitulo, Wim A. Wuyts, Fernando Martinez, Ganesh Raghu
Journal: European Respiratory Journal (2021)

<b>Evidence-based guideline development is challenging. Implementation can be suboptimal. A Delphi survey among clinical experts evaluated possibilities to improve clinical utility and implementation of IPF and other ILD guidelines.</b>http://bit.ly/3avcOug